Alif Saleh

Biolojic Design Ltd. operates as a biopharmaceutical company. The company was founded by Avi Molcho, and Yanay Ofran in 2009 and is headquartered in Givat Shmuel, Israel.

Oral Science, Inc. provides medical devices. The firm’s products include X-PUR, gengigel, plaque HD, curaprox, fluorimax, periostat, xylimelts, advantage arrest, cetacaine, perichlor, zolar photon and pharmacy availability. The company was founded by Sacha Welzel and Daniel Menard and is headquartered in Quebec, Canada.

Joddes Ltd. is a private company based in Hampstead, Canada. and has subsidiaries in Canada. The CEO of the Canadian company is Marc Pierre Martin Rouleau.

Battery Ventures is a private equity and venture capital firm is founded in 1983. The firm is headquartered in Boston, Massachusetts.

Conductor, Inc. is a content technology company, which engages in the provision of search engine optimization measurement tools. It offerssupports and services including site audits, site migrations, content strategy. The company was founded by Richard Safran, Selina Eizik, Seth Besmertnik and Jeremy Duboys in 2005 and is headquartered in New York, NY.

KeyMe LLC provides security software applications. It offers an application that allows users to store, share, and duplicate their physical keys based on a digital scan that is stored in the cloud. The firm's KeyMe app, helps users to secure mail order keys by using a variety of key designs including sports, charity, designer, and bottle opener key. The company was founded by Gregory A. Marsh and Kris Borer in 2012 and is headquartered in New York, NY.

Benson Capital Partners (Benson Capital) is a private equity/venture capital firm founded in 2019 by Gayle Benson. The firm is headquartered in New Orleans, Louisiana.

Prosus Ventures (Prosus) is a venture capital subsidiary of Naspers Ltd founded in 2015. The firm is headquartered in Cape Town, South Africa.

EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA.

Impopharma, Inc. engages in developing and testing of pulmonary and nasal drug delivery systems and ophthalmic, otic, and dermal products. The company was founded by Hanna Piskorz and Harold Wulffhart in 1996 and is headquartered in Concord, Canada.

Lumos Pharma Sub, Inc. develops and commercializes a novel treatment for the rare disease creatine transporter deficiency. It focuses on bringing novel therapies to patients afflicted with unmet medical needs in severe, rare, and genetic diseases. The firm's technology LUM-001 is a repurposed small molecule that is a kinetically similar analog of creatine and has shown promising therapeutic potential for the treatment of creatine transporter deficiency. Lumos Pharma was founded by Richard J. Hawkins in 2010 and is headquartered in Austin, TX.

SwanBio Therapeutics, Inc. operates as a gene therapy firm. The company was founded by Tom Anderson, Rachel Salzman, Karen Kozarsky and Florian S. Eichler and is headquartered in Bala Cynwyd, PA.

Bioceptive, Inc. develops medical devices for gynecological procedures. Its products includes, intrauterine device (IUD) inserter that vastly simplifies the insertion procedure, while reducing the complications inherent with current insertion techniques. The company was founded by Shuchi Khurana and Benjamin D. Cappiello in September 2010 and is ehadquartered in New Orleans, LA.

Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY.

Lodo Therapeutics Corp. engages in the development of novel therapeutics from its metagenomics-based small molecule discovery platform. Its Lodo platform leverages breakthroughs in next-generation sequencing (NGS), artificial intelligence (AI), and machine learning (ML), along with advances in synthetic biology and automation. The company was founded by Sean Brady and David L. Pompliano and is headquartered in New York, NY.

Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom.

Biopticon Corp. operates as a developer, manufacturer, and marketer of measurement and data management systems for pre clinical animal studies. It offers Tumorimager 2, Tumorimager, and Tumormanager. The company was founded by Ibrahim Cem Girit in 2004 and is headquartered in Princeton, NJ.

Nicoventures Trading Ltd. researches, develops, manufactures and delivers tobacco harm reduction products and services. The firm provides innovative and sustainable solutions to global problems arising from smoking and smoking-related illnesses. The company develops ortfolio of products and services focused on smoking cessation and harm reduction, including user-friendly nicotine delivery systems and patient-focused smoking cessation and support services. The company was founded by Christopher John Lord and David Thomas Newns in September 2008 and is headquartered in Manchester, the United Kingdom.

MicroBiome Therapeutics LLC develops drug therapies for metabolic diseases. Its microbiome modulators are designed to augment the growth of certain desirable bacterial strains and discourage the growth of others. The company was founded by John B. Elstrott and Dale R. Pfost in 2009 and is headquartered in New Orleans, LA.

Orchid Cellmark, Inc. provides DNA testing services. It generates genetic profile information by analysing an organism's unique genetic identity. The firm also offers non-DNA forensic laboratory services. The company was founded on March 8, 1995 and is headquartered in Princeton, NJ.

Part of GSK Plc, Smithkline Beckman Corp is a company that manufactures pharmaceutical products. The company is based in Philadelphia, PA. Smithkline Beckman was acquired by Smithkline Beecham Plc on July 27, 1989 for $16,082.37 million.